{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:20:50Z","timestamp":1791429650455,"version":"4.3.3"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sterile State Inc.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    The success of terminal sterilization is a critical step for medical device manufacturing to guarantee device functionality and limit infections. The Food and Drug Administration (FDA) Established Category A approved sterilization methods include heat (steam or dry), radiation (gamma, X-ray, electron beam), ethylene oxide (EtO) gas, and vaporized hydrogen peroxide (VH\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    ). Although EtO is the most commonly used method in the industry, its high toxicity has always been a major concern for human health, environmental impact, and medical device integrity. The developement of novel alternative technologies are actively encouraged by the FDA, aiming to provide similar scalable sterility assurance level (SAL) as EtO gas while reducing health and environmental issues. Nitric oxide (NO) gas was evaluated as the novel sterilant provided by Sterile State Inc. (Grand Rapids, MI) to achieve SAL of 10\n                    <jats:sup>\u22126<\/jats:sup>\n                    at room temperature (RT) and regular atmospheric conditions (21% oxygen and ambient pressure). Commercially available biological indicators (BIs) designed for heat, EtO, and VH\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    , and widely used spore species, including\n                    <jats:italic>B. atrophaeus, B. subtilis<\/jats:italic>\n                    and\n                    <jats:italic>G. stearothermophilus<\/jats:italic>\n                    , were used to validate the NO sterilization system. All the species showed a Log-linear reduction pattern under NO sterilization according to ISO 11138\u22121 guidelines, and the\n                    <jats:italic>D<\/jats:italic>\n                    -values of these microorganisms were determined. NO\u2019s ability to inactivate clinically relevant bacteria,\n                    <jats:italic>E. coli<\/jats:italic>\n                    and\n                    <jats:italic>S. aureus<\/jats:italic>\n                    , was also evaluated through\n                    <jats:italic>D<\/jats:italic>\n                    -values. The sterilization cycle was performed at RT, specifically at 21\u221223 \u00b0C, regular atmospheric pressure, and the NO dose potentially exposed to end-users was significantly less than National Institute for Occupational Safety and Health (NIOSH) defined human Immediately Dangerous to Life or Health (IDLH) level. For the first time, we proved the utility and effectiveness of NO as an agent to achieve sterilization at mild conditions using BI and the SAL of 10\n                    <jats:sup>\u22126<\/jats:sup>\n                    standard. NO sterilization holds great potential to be used as a green alternative to traditional gaseous sterilant sterilization for medical device manufacturing and infection control.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0355735","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:28:16Z","timestamp":1787333296000},"page":"e0355735","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using nitric oxide (NO) for gas sterilization at room temperature: A novel sterilization modality"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4595-7127","authenticated-orcid":true,"given":"Weilue","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"pone.0355735.ref001","volume-title":"Content and format of premarket notification [510 (k)] submissions for liquid chemical sterilants\/high level disinfectants. Guidance for Industry and FDA Reviewers","author":"Food and Drug Administration","year":"2000"},{"key":"pone.0355735.ref002","volume-title":"Medical device sterilization market \u2013 industry trends and forecast to 2030","author":"Data Bridge Market Research","year":"2023"},{"key":"pone.0355735.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2023.01.020","article-title":"Sterilization of 20 billion medical devices by ethylene oxide (ETO): Consequences of ETO closures and alternative sterilization technologies\/solutions","volume":"51","author":"WA Rutala","year":"2023","journal-title":"Am J Infect Control"},{"key":"pone.0355735.ref004","unstructured":"Rutala WA. Guideline for disinfection and sterilization in healthcare facilities; 2008. Available from: http:\/\/www.cdc.gov\/ncidod\/dhqp\/pdf\/guidelines\/Disinfection_Nov_2008.pdf"},{"issue":"5","key":"pone.0355735.ref005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood.V57.5.946.946","article-title":"Evidence for the inhibitory role of guanosine 3\u2032, 5\u2032-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators","volume":"57","author":"BT Mellion","year":"1981","journal-title":"Blood"},{"issue":"3","key":"pone.0355735.ref006","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1476-5381.1987.tb11367.x","article-title":"The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide","volume":"92","author":"MW Radomski","year":"1987","journal-title":"Br J Pharmacol"},{"issue":"8","key":"pone.0355735.ref007","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.biomaterials.2004.03.031","article-title":"Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants","volume":"26","author":"BJ Nablo","year":"2005","journal-title":"Biomaterials"},{"issue":"4","key":"pone.0355735.ref008","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jbm.a.30359","article-title":"Mediation of in vivo glucose sensor inflammatory response via nitric oxide release","volume":"75","author":"R Gifford","year":"2005","journal-title":"J Biomed Mater Res Part A"},{"issue":"23","key":"pone.0355735.ref009","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1161\/01.CIR.0000017432.19415.3E","article-title":"Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty","volume":"105","author":"SH Baek","year":"2002","journal-title":"Circulation"},{"issue":"22","key":"pone.0355735.ref010","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1073\/pnas.86.22.9030","article-title":"Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum","volume":"86","author":"DS Bredt","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pone.0355735.ref011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00253-010-2733-x","article-title":"Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices","volume":"88","author":"ML Jones","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"issue":"30","key":"pone.0355735.ref012","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1016\/j.biomaterials.2008.07.005","article-title":"Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release","volume":"29","author":"GW Charville","year":"2008","journal-title":"Biomaterials"},{"key":"pone.0355735.ref013","unstructured":"Osborne JJ. Inhibition of bacterial growth and prevention of bacterial adhesion with localized nitric oxide delivery. Michigan Technological University; 2016."},{"issue":"8","key":"pone.0355735.ref014","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1039\/C6BM00271D","article-title":"Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO)","volume":"4","author":"Y Wo","year":"2016","journal-title":"Biomater Sci"},{"key":"pone.0355735.ref015","unstructured":"Hampl V, Walters LC, Archer LS. Determination of nitric oxide by the chemiluminescence reaction with ozone. In: Feelisch M, Stamler JS, editors. Methods in nitric oxide research. 1996. p. 309\u201319."},{"issue":"7","key":"pone.0355735.ref016","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.freeradbiomed.2004.06.019","article-title":"Nitric oxide-releasing hydrophobic polymers: preparation, characterization, and potential biomedical applications","volume":"37","author":"MM Reynolds","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"pone.0355735.ref017","volume-title":"Nitric oxide: immediately dangerous to life or health concentrations (IDLH)","author":"National Institute for Occupational Safety and Health","year":"1994"},{"key":"pone.0355735.ref018","doi-asserted-by":"crossref","unstructured":"Beckman JS. The physiological and pathological chemistry of nitric oxide. In: Nitric oxide: principles and actions, vol. 21; 1996.","DOI":"10.1016\/B978-012435555-2\/50002-4"},{"issue":"6122","key":"pone.0355735.ref019","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"RM Palmer","year":"1987","journal-title":"Nature"},{"key":"pone.0355735.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2016.05.002","article-title":"Direct measurement of actual levels of nitric oxide (NO) in cell culture conditions using soluble NO donors","volume":"9","author":"W He","year":"2016","journal-title":"Redox Biol"},{"issue":"1","key":"pone.0355735.ref021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/niox.1996.0112","article-title":"A tutorial on the diffusibility and reactivity of free nitric oxide","volume":"1","author":"JR Lancaster","year":"1997","journal-title":"Nitric Oxide"},{"key":"pone.0355735.ref022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3140109","article-title":"Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase","author":"M Laurent","year":"1996","journal-title":"Biochem J"},{"key":"pone.0355735.ref023","unstructured":"BacDive. Geobacillus stearothermophilus (Strain ID 1420). Braunschweig, Germany: Leibniz Institute DSMZ; [updated 2026 May 29; cited 2026 Jun 22]. Available from: https:\/\/bacdive.dsmz.de\/strain\/1420"},{"key":"pone.0355735.ref024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.fm.2015.12.007","article-title":"Die another day: fate of heat-treated Geobacillus stearothermophilus ATCC 12980 spores during storage under growth-preventing conditions","volume":"56","author":"N Mtimet","year":"2016","journal-title":"Food Microbiol"},{"issue":"10369","key":"pone.0355735.ref025","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"KS Ikuta","year":"2022","journal-title":"The Lancet"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:28:21Z","timestamp":1787333301000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355735"}},"subtitle":[],"editor":[{"given":"Paulo","family":"Laranjeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355735","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}